Vimarsana
Biggest News Aggregation in the World

Report Co Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Report Co Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Report Co Author Today - Breaking & Trending Today

Analysis: Europe's PSM need regulatory support | Advanced Television - Vimarsana News

Analysis: Europe's PSM need regulatory support | Advanced Television

Consumer research carried out by Ampere Analysis over the last six years has revealed that engagement with public service media (PSM) linear or their Video on D

BBC, ZDF & Other Euro Public Service Networks See Viewer Engagement Dwindling — Ampere Study - Vimarsana News

BBC, ZDF & Other Euro Public Service Networks See Viewer Engagement Dwindling — Ampere Study

The BBC, ARD/ZDF and other major European public service networks have seen viewer engagement in their services dive by nearly a fifth in the past six years, an Ampere Analysis study revealed today. The consumer research shows public service media (PSM)’s linear and Video on Demand (BVoD) services has fallen by 15% in Europe’s largest …

Source: yahoo.com
BBC, ZDF & Euro Counterparts Losing Younger Viewers — Ampere – Deadline - Vimarsana News

BBC, ZDF & Euro Counterparts Losing Younger Viewers — Ampere – Deadline

The BBC, ARD/ZDF and other major European public service networks are seeing a fall in viewer engagement, an Ampere Analysis study revealed today.

NIH Strips Wuhan Lab of Eligibility for Animal Experiment Funding - Vimarsana News

NIH Strips Wuhan Lab of Eligibility for Animal Experiment Funding

The NIH stripped China's Wuhan Institute of Virology (WIV) of its eligibility to receive American taxpayer funding for animal experiments.

NIH Strips Wuhan Lab of Eligibility for Animal Experiment Funding - Vimarsana News

NIH Strips Wuhan Lab of Eligibility for Animal Experiment Funding

The NIH stripped China's Wuhan Institute of Virology (WIV) of its eligibility to receive American taxpayer funding for animal experiments.